Gastrin and colorectal cancer: a prospective study

Area of Science:

• Gastroenterology
• Oncology
• Epidemiology

Background:

• Gastrin is implicated as a potential promoter of colorectal cancer development.
• Understanding the temporal link between gastrin levels and colorectal malignancy is crucial.

Purpose of the Study:

• To investigate the relationship between serum gastrin levels and the subsequent development of colorectal cancer.
• To evaluate gastrinemia as a risk factor for colorectal malignancy.

Main Methods:

• A nested case-control study was conducted using serum samples from 128,992 health program subscribers (1964-1969).
• 250 colorectal cancer cases were matched with controls; stored sera were analyzed for gastrin and glycine-extended gastrin.
• Helicobacter pylori immunoglobulin G was also measured.

Main Results:

• A mean follow-up of 15.3 years occurred between serum collection and cancer diagnosis.
• While median gastrin levels were similar between cases and controls, elevated gastrin was associated with a 3.9-fold increased risk of colorectal cancer.
• An estimated 8.6% of colorectal cancers could potentially be attributed to high serum gastrin levels.

Conclusions:

• Hypergastrinemia is significantly associated with an elevated risk of developing colorectal carcinoma.
• These findings support a role for gastrin in the pathogenesis of colorectal cancer.